The US may be one of the planet’s most well-resourced countries, but it’s clearly doing a much worse job of providing health care—particularly mental health care—than many countries.

A new Alzheimer’s drug has secured FDA approval for the first time in nearly 2 decades, and not everyone is happy about it.   Biogen’s new drug, Aduhelm, is expensive ($56,000 per year) and highly controversial:

Rates of teen depression have spiraled in the past decade—mental health researchers believe social media may have a large role to play,

Police mistake someone who is mentally ill as an immediate threat, and the person in crisis ends up dead at the hands of law enforcement.  

Pain research has long relied on methods like the McGill Pain Questionnaire, which helps doctors treat pain by prompting patients to attach a certain vocabulary and meaning to it. But people with Alzheimer’s can be robbed of the cognitive ability to communicate their pain—…

As countries scramble to respond to the pandemic, mental health professionals are warning of an emerging youth mental health crisis,

The stress of the pandemic led to the suicide of a 35-year-old Canadian emergency physician this month.  

The dominant origin story of Alzheimer’s focuses on the build-up of amyloid protein “clumps” on the brain.  

Psilocybin, the active ingredient in magic mushrooms, worked better than standard antidepressants in treating major depressive disorder in a rigorous 

Investing in mental health. The theme for this year’s World Mental Health Day—held every year on October 10—speaks to the growing acknowledgment of a massive global need. While gaps in mental health care have been exacerbated by the isolation, anxiety, and service…